Conclusions
Post# of 30028
The LymProtest, which measures mitogenicresponse to peripheral blood lymphocytes, demonstrates acceptable pre-analytical and analytical variation in this study. The test will transition into multiple clinical studies for differentiation of individuals at risk for Alzheimer’s Disease from other dementias.